Recombinant modified human growth hormone (Richardson Associates Regulatory Affairs)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant modified human growth hormone (Richardson Associates Regulatory Affairs)
Drug Alias NamehGH (Richardson Associates Regulatory Affairs)重组修饰人生长激素 (Richardson Associates Regulatory Affairs)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesRichardson Associates Regulatory Affairs Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRichardson Associates Regulatory Affairs Ltd
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiency

Other Information

ATC CodeN/A
Related LinksN/A